A planned state-of-the-art facility for integrated life sciences research, Danoff Laboratories in Providence’s Jewelry District will convene scientists to solve complex, interconnected health and medical challenges.
The sixth floor of 225 Dyer St. has been outfitted with much-needed life sciences lab space to welcome Brown University researchers and encourage innovation and collaboration.
At Brown’s Legorreta Cancer Center, Dr. Sean Lawler and his team of researchers are exploring a new treatment for cancer that uses the body’s own immune system to target brain tumors.
The ambitious goal of the new Brown RNA Center is to untangle the mysteries of human RNA, which could be instrumental in preventing and developing treatments for a wide variety of complex diseases.
Researchers at the Center for Alzheimer’s Disease Research are examining how risk factors and neuropsychiatric patterns may hold the key for early detection, and early intervention, in this fast-growing disease.
The Legorreta Cancer Center is hosting two visiting oncologists from Kyiv whose work and lives were interrupted when Russia invaded their country in 2022.
International Space Station experiments co-led by Peter Lee, a Brown scholar, cardiothoracic surgeon and longtime space researcher, will help inform understanding and treatment of cardiovascular disease.
The research leader in cardiology and gene therapy reflects on her family’s history of giving back and explores how Brown has been a foothold to grow her remarkable career.
As Brown works to expand its research enterprise, the Division of Biology and Medicine will play a central role in discovering and disseminating solutions to the world’s most pressing medical problems.
Researchers from Brown University, Michigan State and Henry Ford Health are leading a multi-institution research effort to reduce the national suicide rate.
Appointed Brown’s 19th president in 2012, Christina H. Paxson has guided the University through major accomplishments and national moments of challenge, and she looks forward to achieving more in the years to come.
Patients can’t always prepare for a medical emergency. With donor support, Brown’s Department of Emergency Medicine can make sure the physicians who treat them are.
Early detection. Personalized treatments. Collaborative care. The Center for Alzheimer’s Disease Research is positioning Brown to improve patient outcomes now and in the future.
Brown researchers are pursuing a promising new method that could transform toxicology testing, making it faster and more effective without the use of animals.
By blurring the line between patient care and clinical research, this dual degree might be our best chance to tackle some of the most pressing health issues of our time.
Generous gifts totalling $30 million are supporting the establishment of the Center for Alzheimer’s Disease Research at Brown, with a focus on early detection and viable treatments.
Sandi Nusinoff Lehrman ’69 MD’76 and Stephen A. Lehrman ’73 have seen two grandchildren battle a rare neurological disease. Through their philanthropy, they're supporting Brown's Center for Translational Neuroscience in its crusade to discover new treatments for rare brain diseases.
Cancer doesn’t take a break, not even for a worldwide pandemic. The newly established Cancer Center at Brown University, directed by Dr. Wafik El-Deiry, is making sure advances in research and improvements to patient care continue uninterrupted.
From providing emergency support to students during a global pandemic to game-changing research in malaria, we're looking back at some important accomplishments supported by Brown donors in a year that was anything but ordinary.
Recent hires, game-changing grants, and collaboration are helping to position Brown’s Carney Institute for Brain Science as a global leader in Alzheimer’s research and treatment.
As a practicing emergency physician, Dr. Megan Ranney MPH’10 RES’08 believes that the emergency department is where you can change a patient’s health care trajectory. And technology is her tool of choice.
Professor Eric Morrow and his team of researchers are using genetics to speed up the diagnosis and treatment of autism in children—and to provide hope to families.
Brown’s new Biomedical Innovation Fund has made two grants to accelerate the commercialization of technologies — one for diagnosing drug dependence in newborns and a second for discovering anti-ALS medicines.